本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

阿尔尼拉姆制药公司

300.83
-7.1700-2.33%
盘后297.00-3.8300-1.27%17:34 EDT
成交量:95.48万
成交额:2.89亿
市值:392.25亿
市盈率:-143.37
高:310.22
开:309.00
低:300.27
收:308.00
数据加载中...
2025/01/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/13

重要事件披露

Form 8-K - Current report
2024/12/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/08

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/10/31

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/10/31

重要事件披露

Form 8-K - Current report
2024/08/22

SEC问询函

Form CORRESP - Correspondence
2024/08/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/01

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/01

重要事件披露

Form 8-K - Current report
2024/07/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/25

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/20

重要事件披露

Form 8-K - Current report